Jason Butler
Stock Analyst at Citizens JMP
(4.83)
# 442
Out of 4,596 analysts
712
Total ratings
51.2%
Success rate
18.3%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LONA LeonaBio | Upgraded: Buy | $18 | $7.06 | +154.96% | 35 | Jul 30, 2026 | |
| ARGX argenx SE | Maintained: Buy | $944 → $932 | $853.82 | +9.16% | 43 | Jul 24, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $18 → $25 | $9.51 | +162.88% | 10 | Jun 9, 2026 | |
| RZLT Rezolute | Upgraded: Buy | $11 | $4.72 | +133.05% | 33 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $131 → $187 | $124.92 | +49.70% | 14 | Jun 2, 2026 | |
| GHRS GH Research | Maintained: Buy | $42 → $39 | $28.07 | +38.94% | 24 | May 15, 2026 | |
| PGEN Precigen | Maintained: Buy | $9 → $11 | $6.27 | +75.44% | 49 | May 14, 2026 | |
| AVTX Avalo Therapeutics | Maintained: Buy | $62 → $55 | $18.25 | +201.37% | 3 | May 14, 2026 | |
| PRTA Prothena Corporation | Maintained: Buy | $19 → $20 | $8.12 | +146.31% | 27 | May 8, 2026 | |
| NERV Minerva Neurosciences | Initiated Coverage: Buy | $14 | $3.98 | +251.76% | 19 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $18 | $3.03 | +494.06% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $35 | $25.87 | +35.29% | 48 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $10 | $4.23 | +136.41% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $96 | $77.13 | +24.47% | 62 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $6.42 | +195.95% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $77 → $80 | $40.98 | +95.22% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 → $92 | $82.54 | +11.46% | 48 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $12 | $3.70 | +224.76% | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $7.53 | +192.16% | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $38 | $18.92 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0111 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2095 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $23.39 | n/a | 8 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.45 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.22 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €367.56 | €748.00 | n/a | 1 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $70 | $82.35 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.82 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.92 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $5.10 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.00 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $320.56 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.91 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $45.96 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $10.01 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.22 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.88 | n/a | 1 | Mar 26, 2013 |
LeonaBio
Jul 30, 2026
Upgraded: Buy
Price Target: $18
Current: $7.06
Upside: +154.96%
argenx SE
Jul 24, 2026
Maintained: Buy
Price Target: $944 → $932
Current: $853.82
Upside: +9.16%
Zevra Therapeutics
Jun 9, 2026
Maintained: Buy
Price Target: $18 → $25
Current: $9.51
Upside: +162.88%
Rezolute
Jun 3, 2026
Upgraded: Buy
Price Target: $11
Current: $4.72
Upside: +133.05%
ABIVAX Société Anonyme
Jun 2, 2026
Maintained: Buy
Price Target: $131 → $187
Current: $124.92
Upside: +49.70%
GH Research
May 15, 2026
Maintained: Buy
Price Target: $42 → $39
Current: $28.07
Upside: +38.94%
Precigen
May 14, 2026
Maintained: Buy
Price Target: $9 → $11
Current: $6.27
Upside: +75.44%
Avalo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $62 → $55
Current: $18.25
Upside: +201.37%
Prothena Corporation
May 8, 2026
Maintained: Buy
Price Target: $19 → $20
Current: $8.12
Upside: +146.31%
Minerva Neurosciences
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $3.98
Upside: +251.76%
Mar 26, 2026
Maintained: Buy
Price Target: $19 → $18
Current: $3.03
Upside: +494.06%
Feb 26, 2026
Maintained: Buy
Price Target: $38 → $35
Current: $25.87
Upside: +35.29%
Feb 26, 2026
Maintained: Buy
Price Target: $8 → $10
Current: $4.23
Upside: +136.41%
Feb 25, 2026
Maintained: Buy
Price Target: $88 → $96
Current: $77.13
Upside: +24.47%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $6.42
Upside: +195.95%
Nov 7, 2025
Maintained: Buy
Price Target: $77 → $80
Current: $40.98
Upside: +95.22%
Nov 4, 2025
Maintained: Buy
Price Target: $91 → $92
Current: $82.54
Upside: +11.46%
Oct 9, 2025
Maintained: Buy
Price Target: $9 → $12
Current: $3.70
Upside: +224.76%
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $7.53
Upside: +192.16%
May 7, 2025
Maintained: Buy
Price Target: $42 → $38
Current: $18.92
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.2095
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $23.39
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.45
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.22
Upside: n/a
Feb 1, 2021
Maintained: Buy
Price Target: €367.56
Current: €748.00
Upside: n/a
Jan 9, 2020
Maintained: Buy
Price Target: $58 → $70
Current: $82.35
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.82
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.92
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $5.10
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $3.00
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $320.56
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.91
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $45.96
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $10.01
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $12.22
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $1.88
Upside: n/a